Design, Synthesis, <i>In Vitro</i> and <i>In Vivo</i> Characterization of Selective NKCC1 Inhibitors for the Treatment of Core Symptoms in Down Syndrome.
第一作者:
Marco,Borgogno
第一单位:
Molecular Modeling and Drug Discovery Laboratory, Istituto Italiano di Tecnologia, via Morego, 30, 16163 Genoa, Italy.
作者:
医学主题词
动物(Animals);细胞, 培养的(Cells, Cultured);剂量效应关系, 药物(Dose-Response Relationship, Drug);唐氏综合征(Down Syndrome);药物设计(Drug Design);女(雌)性(Female);HEK293细胞(HEK293 Cells);人类(Humans);男(雄)性(Male);小鼠(Mice);小鼠, 近交C57BL(Mice, Inbred C57BL);小鼠, 转基因(Mice, Transgenic);分子结构(Molecular Structure);构效关系(Structure-Activity Relationship)
DOI
10.1021/acs.jmedchem.1c00603
PMID
34137257
发布时间
2021-10-06
- 浏览3
Journal of medicinal chemistry
10203-10229页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文


换一批



